Redx Pharma PLC
16 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded as renamed to Redx Pharma Limited (2024)
0
Ending by 2030
Jan 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 20, 2027The maintenance fee for Antibacterial compounds (US 10,385,065) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,682,963 | Pyridine derivatives as soft rock inhibitors In force · USPTO record | In force | USPTO record | |
| US 9,850,234 | Pyridine derivatives as soft rock inhibitors In force · USPTO record | In force | USPTO record | |
| US 10,385,065 | Antibacterial compounds In force · USPTO record | In force | USPTO record | |
| US 10,047,079 | N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway In force · USPTO record | In force | USPTO record | |
| US 10,202,375 | N-Pyridinyl Acetamide Derivatives as WNT Signalling Pathway Inhibitors In force · High confidence | In force | High confidence | |
| US 10,793,560 | N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway In force · USPTO record | In force | USPTO record | |
| US 10,793,562 | N-Pyridinyl Acetamide Derivatives as WNT Signalling Pathway Inhibitors In force · Medium confidence | In force | Medium confidence | |
| US 11,459,326 | N-Pyridinyl Acetamide Derivatives as WNT Signalling Pathway Inhibitors In force · Medium confidence | In force | Medium confidence | |
| US 12,202,826 | N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway In force · USPTO record | In force | USPTO record | |
| US 11,643,408 | N-Pyridinyl Acetamide Derivatives as Inhibitors of the WNT Signaling Pathway In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 10: 16 patents in force now held by others · 15 lapsed for an unpaid fee · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 2 abandoned · 2 no status recorded
Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 17/822,871 | N-Pyridinyl Acetamide Derivatives as WNT Signalling Pathway Inhibitors | Aug 29, 2022 | Abandoned |
| 18/565,009 | Quinazoline Derivatives Useful as Ras Inhibitors | Jun 9, 2022 | Pending |
| 18/562,608 | PYRIDO[4,3-D]PYRIMIDINE Compounds Capable of Inhibiting Kras Mutant Proteins | May 27, 2022 | Pending |
| 18/271,913 | Pharmaceutical Formulation | Jan 14, 2022 | Abandoned |
| 16/074,899 | Feb 8, 2017 | No status recorded | |
| 16/074,853 | Feb 8, 2017 | No status recorded |